KEY DETAILS
A lawsuit between Eli Lilly and Company and Willow Health Services, Inc. is pending in the Ninth Circuit, and the latest docket action is dated March 5, 2026.
A lawsuit between Eli Lilly and Company and Willow Health Services, Inc. is pending in the Ninth Circuit Court of Appeals. Eli Lilly makes GLP-1 medications, but the docket does not say what the dispute is actually about, so there is little we can tell you beyond the fact that it exists.
The case, captioned Eli Lilly and Company v. Willow Health Services, Inc., is pending in the Ninth Circuit. Its most recent docket action is dated March 5, 2026. The docket does not describe the subject matter of the dispute, so we cannot say whether it touches on pricing, supply, marketing, patents, or something unrelated to GLP-1 medications. A case being pending simply means it is active and unresolved. It is not a ruling, a settlement, or any kind of finding against either party.
At this stage, the most accurate thing we can tell you is that this case exists and remains unresolved. We would caution against reading anything further into it until more details become available, whether that means the underlying claims, the parties' arguments, or any outcome from the court.
Originally published on GLP1Laws.
Every Sunday, the weekly newsletter pulls the full week together: the news from GLP-1 Nation, the access updates from GLP1Laws, the latest GLP-1 Studio podcast episodes, and what changed in the Cozy Butter community.